About the Morgridge Institute for Research
The Morgridge Institute for Research is a new, private, not-for-profit interdisciplinary biomedical research organization dedicated to the vision of “Discovery to Delivery,” of accelerating the movement of science from the laboratories of researchers to public use around the world as treatments and cures. It is associated with and located on the campus of the University of Wisconsin-Madison, consistently one of the top research universities in the world.
The Morgridge Institute is part of the twin institutes of the Wisconsin Institutes for Discovery, a public-private initiative that facilitates interdisciplinary research and breakthrough discoveries to advance human health and well-being. The new state-of-the-art facility housing the institutes opened in December 2010.
The Morgridge Institute for Research leverages the best of a great public university with the flexibility and resources of a world-class private research institute. Its goal is to improve human health by improving the way scientists collaborate, discover, deliver and educate. The Morgridge Institute brings together world-class scientists to facilitate research collaborations across the fields of biology, computer science and bioengineering.
The institute is led by acclaimed scientist James Dahlberg as interim executive director. Stem cell pioneer Dr. James Thomson was named as its first scientific director in 2008, and additional scientific leaders including Paul Ahlquist, Thomas Mackie, Sangtae "Sang" Kim, Miron Livny, Susan Millar and Rupa Shevde have been selected. The initial programming of the Morgridge Institute for Research focuses on:
- Regenerative Biology
- Virology
- Medical Devices
- Pharmaceutical Informatics
- Education Research
- Core Computational Technology
In time, the Morgridge Institute hopes to discover new treatments and cures for some of the world’s most devastating diseases, such as Alzheimer’s, hepatitis C, cancer, diabetes and heart disease.
Morgridge Institute Scientific Leaders
Seated from left: Sang Kim, James Thomson
Standing from left: Paul Ahlquist, Susan Millar,
T. Rock Mackie, Miron Livny, Rupa Shevde
“We will focus world-class talent on advancing discoveries in five research challenge areas that have tremendous potential for improving the health of millions of people around the world,” said Sangtae “Sang” Kim, founding executive director of the nonprofit interdisciplinary institute. “Our mission is to accelerate the ability to treat, cure or eradicate such devastating diseases as hepatitis C, cancer, diabetes and heart disease.”
Download high-resolution photos >
